150 related articles for article (PubMed ID: 34752733)
1. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
Said MN; Muawia S; Helal A; Fawzy A; Allam RM; Shafik NF
Exp Mol Pathol; 2021 Dec; 123():104718. PubMed ID: 34752733
[TBL] [Abstract][Full Text] [Related]
2. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
3. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
4. Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway.
Yu B; Gao W; Zhou H; Miao X; Chang Y; Wang L; Xu M; Ni G
Cancer Biomark; 2018 Feb; 21(3):513-519. PubMed ID: 29103019
[TBL] [Abstract][Full Text] [Related]
5. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
[TBL] [Abstract][Full Text] [Related]
6. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
Fernandez S; Risolino M; Mandia N; Talotta F; Soini Y; Incoronato M; Condorelli G; Banfi S; Verde P
Oncogene; 2015 Jun; 34(25):3240-50. PubMed ID: 25151966
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
[TBL] [Abstract][Full Text] [Related]
8. Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27
Chen Y; Du M; Yusuying S; Liu W; Tan Y; Xie P
Exp Cell Res; 2020 Jul; 392(2):112038. PubMed ID: 32360865
[TBL] [Abstract][Full Text] [Related]
9. Circulating status of microRNAs 660-5p and 210-3p in breast cancer patients.
Nashtahosseini Z; Aghamaali MR; Sadeghi F; Heydari N; Parsian H
J Gene Med; 2021 Apr; 23(4):e3320. PubMed ID: 33533518
[TBL] [Abstract][Full Text] [Related]
10. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
12. Starvation stress attenuates the miRNA-target interaction in suppressing breast cancer cell proliferation.
Lü J; Zhang C; Han J; Xu Z; Li Y; Zhen L; Zhao Q; Guo Y; Wang Z; Bischof E; Yu Z
BMC Cancer; 2020 Jul; 20(1):627. PubMed ID: 32631271
[TBL] [Abstract][Full Text] [Related]
13. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
[TBL] [Abstract][Full Text] [Related]
14. The differential regulation of microRNAs is associated with oral cancer.
Tsai SC; Huang SF; Chiang JH; Chen YF; Huang CC; Tsai MH; Tsai FJ; Kao MC; Yang JS
Oncol Rep; 2017 Sep; 38(3):1613-1620. PubMed ID: 28713923
[TBL] [Abstract][Full Text] [Related]
15. miR-24 regulates CDKN1B/p27 expression in prostate cancer.
Lynch SM; McKenna MM; Walsh CP; McKenna DJ
Prostate; 2016 May; 76(7):637-48. PubMed ID: 26847530
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
Zheng M; Sun X; Li Y; Zuo W
Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
[TBL] [Abstract][Full Text] [Related]
18. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
19. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
20. miR-196a-mediated downregulation of p27
Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
